SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 14)*
Sierra Health Services, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
826322-109
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP No. 826322-109
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Anthony M. Marlon, M.D.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) |_|
(B) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
5 SOLE VOTING POWER
NUMBER OF 2,739,154 shares of Common Stock at 12/31/01
SHARES
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0- at 12/31/01
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 2,739,154 shares of Common Stock at 12/31/01
WITH
8 SHARED DISPOSITIVE POWER
-0- at 12/31/01
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,739,154 shares of Common Stock at 12/31/01
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* |X| See Item 4 of attached Schedule 13G
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.7% of outstanding class at 12/31/01
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Item 1. (a) Name of Issuer:
Sierra Health Services, Inc.
(b) Address of Issuer's Principal Executive Offices:
2724 North Tenaya Way
Las Vegas, Nevada 89128
Item 2. (a) Name of Person Filing:
Anthony M. Marlon, M.D. ("Dr. Marlon")
(b) Address of Principal Business Office or, if none, Residence:
2724 North Tenaya Way
Las Vegas, Nevada 89128
(c) Citizenship:
United States of America
(d) Title of Class of Securities:
Common Stock, $.005 par value
(e) CUSIP Number:
826322-109
Item 3. This statement is filed pursuant to Rule 13d-1(c). Items 3(a) through
3(h) are, therefore, inapplicable.
Item 4. Ownership
(a) Amount Beneficially Owned:
Dr. Marlon may be deemed to beneficially own 2,739,154
shares of Common Stock at December 31, 2001. That number of
shares reported as beneficially owned includes 2,329,003
shares held indirectly through a total of four trusts
established by Dr. Marlon and his wife, and 1,500 shares
held indirectly through a limited partnership (the
"Partnership"). Dr. Marlon may be deemed to have or share
voting power and/or dispositive power over the shares held
by the four trusts and, therefore, to have beneficial
ownership with respect to such shares. Dr. Marlon, as
managing general partner of the Partnership, has sole voting
and dispositive power over the shares held by the
Partnership. Dr. Marlon disclaims beneficial ownership as to
the shares held by the four trusts, other than the 1,135,341
shares held by the Marlon Family Trust (a revocable trust of
which he is a trustee). The number of shares reported as
beneficially owned also includes 300,091 shares that Dr.
Marlon has a right to acquire within 60 days of December 31,
2001, upon exercise of options, and includes 108,560 shares
held for Dr. Marlon's account under the Company's 401(k)
plan for employees. Dr. Marlon's beneficial ownership does
not include 163,054 shares held in three trusts for the
benefit of family members, the trustee of each of which is
Erin E. MacDonald, and does not include 652,648 shares held
by the AMM & RM Family Limited Partnership, the general
partner of which is a trust for the benefit of a family
member; the trustees of that trust are Ms. MacDonald,
William Godfrey, and Jeannine M. Zeller (daughter of Dr.
Marlon). Dr. Marlon's beneficial ownership also does not
include 696,181 shares subject to stock options which are
not currently exercisable and will not become exercisable
within 60 days after December 31, 2001 and 204,680 shares
deliverable in settlement of restricted stock units that
will not become settleable within 60 days after December 31,
2001.
(b) Percent of Class:
9.7% of the class of Common Stock outstanding at
December 31, 2001
(c) Number of shares as to which Dr. Marlon has:
(i) sole power to vote or to direct the vote:
2,739,154 shares of Common Stock at
December 31, 2001 (see Item 4(a) above.)
(ii) shared power to vote or to direct the vote:
-0- shares of Common Stock at December 31, 2001
(iii) sole power to dispose or to direct the disposition of:
2,739,154 shares of Common Stock at
December 31, 2001 (see Item 4(a) above.)
(iv) shared power to dispose or to direct the disposition of:
-0- shares of Common Stock at December 31, 2001
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification.
Not applicable. This statement is filed pursuant to Rule 13d-1(d).
The filing of this Amendment to Schedule 13G and amendments hereto, and the
statements herein and therein, shall not be construed as an admission that any
filing person or any other person named herein is, for purposes of Section
13(d), 13(g), 16(a), or 16(b) under the Exchange Act, or for any other purpose,
the beneficial owner of any of the securities described herein or therein,
except to the extent that a natural person is reported as having voting and
dispositive power, and thus beneficial ownership for purposes of Sections 13(d)
and 13(g), over securities owned directly by such person.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 7, 2002
-----------------------------------
Date
/s/ Anthony M. Marlon, M.D.
-----------------------------------
ANTHONY M. MARLON, M.D.
Name/Title